Mumps, Measles, slow Flashcards
Measles, mumps vs flu
All hemagglutinate
Mumps is antigenetically similar to parainfluenza
BUT
Single strand RNA -> no genetic reassortment -> no rapid antigen shifts
Flu (ortho) and paraflu (paramyxo) both local, nonviremic
Measles, mumps (paramyxo) systemic, viremic (longer incubation, lifelong immunity via IgG)
Paramyxoviruses
Single (-) RNA
Helical, envelope
Must carry RNA polymerase in virion
Mumps epidemiology
One serotype, only in humans ->
effective vaccine has decreased cases
lifelong immunity even after subclinical infection
Transmission = respiratory (saliva)
Infectious before and after symptoms
Incubation 18-21 days
Mumps presentation
Incubation 18-21 days
Prodrome = fever, malaise, anorexia
PAROTIDITIS - unilateral or bilateral, swelling, inflamed duct
Can also have orchitis, aseptic meningitis, pancreas, ovaries
No therapy
Mumps vaccine
Live attenuated
Part of MMR
Given in two low doses to minimize side effects
Effective drop in incidence when introduced (60’s)
Still epidemics in unvaccinated pockets (UK, summer camp)
Endemic in Africa
Mumps pathogenesis
Respiratory transmission ->
obligatory viremia (IgG response) ->
parotid gland -> duct -> mouth ->
shed in saliva
Measles epidemiology
Most contagious disease known!
Exposure (resp, tears, urine) -> almost 100% infection -> 100% symptoms
Only humans, enveloped/unstable -> requires large susceptible population
Pre-vaccine: cyclical epidemics every 3 years
(no antigenetic variation -> new births susceptible-> no herd immunity -> rapid spread)
Measles presentation
Respiratory -> resp epithelium -> lymph ->
VIREMIA ->
prodrome = fever, URI, conjunctivitis = infectious shedding! ->
Koplik’s spots (red with white) on mucosa ->
rash, photophobia, fever, URI, conjunctivitis
Incubation = 14 days
No treatment
Measles complications
More likely in adult, immunocompromised (partially dt immune response)
1:20 -> bacterial pneumonia
- giant cell pneumonia - can occur without rash
frequent otitis media (bact)
acute encephalitis (1-2:1000)
deaths (1-3:1000)
Measles pathophysiology
Syncytia - viral membrane proteins -> fusion -> large multinucleated cells in lymphoid, resp
- damage without IgG exposure
- > giant cell pneumonia
Anergy - grows in T cells -> severely depresses cell-mediated immunity -> secondary infections -> death
Measles in developing world
Higher mortality!
5-25% vs can’t regenerate immune system)
Reduced mortality from Vitamin A (best ROI for global health!)
Eradicated from US but 50-100 cases imported each year
Measles vaccine
Live attenuated
Part of MMR -> given twice
Must maintain herd immunity due to high infectivity
How to eradicate? Vaccine not effective megadoses earlier?
Slow virus overview
Long incubation (years) -> slow death
Can have latency -> reemerge with immune compromise
Often genetic predisposition
Ex HIV, PML, SSPE, BK nephropathy (transplant failure)
PML
Progressive multifocal leukoencephalopathy
JC virus (papovavirus) -> CNS oligodendroglia ->
Immune compromise activates -> demyelination ->
Blind, dementia, coma, death
No inflammation
SSPE
Subacute sclerosing pan-encephalitis
Insidious neuro/psych -> blind -> paralysis -> death
Measles and inclusion bodies in CNS, high antibody titers
Early, subclinical infection -> ? mechanism unclear, no CTL in CNS?
Can occur after vaccine but lower risk (1:million vs 1:100K)